EPCAM and hepatocellular carcinoma: It has been proven that EpCAM-positive CTCs may serve as a prognostic marker in HCC after curative resection, as overexpression of EpCAM is significantly associated with the poor clinical outcome of HCC (Sun et al., 2013).